Toshihiro Shioda's guest appearances

Toshihiro Shioda

Finding Genius Podcast

FutureTech Podcast

Laura Jana

Stephen Greiman

Andres M. Gomez

Drew Manning

David Ewing

Aubrey de Grey

Abby Johnson

Ross Taylor

Mary T. Newport

Thomas Neumann

Craig Mickanin

Amy Berger

Ilan Morad

Jamie Burke

Natasha Lilly

OwlTail

In this informative podcast, Toshihiro Shioda, MD, Associate Professor, Medicine, Harvard Medical School, provides an overview of the current research in cellular biology, with a focus on primordial germ cells. As a noted researcher, Toshihiro Shioda, MD, Ph.D., has devoted a great deal of his life to the study of cellular activity and cellular processes. Shioda’s lab researches a vast array of important scientific areas including the role of estrogens and antiestrogens in human breast cancer. Shioda and his team have a particular interest in primordial germ cells (PGCs).  His research team studies how primordial germ cells share similarities to common, natural germ cells. And Shioda’s research may deliver a working model that could facilitate the analyzation of germline epimutations. The Ph.D. researcher discusses the details of chemotherapy and its impact on both sexes. Additionally, he cites various research regarding epigenetics. By using the leading tools available to them, Shioda and his team hope to deliver effective germ cell models that will be viable for cancer research as well as other areas of study.

In this informative podcast, Toshihiro Shioda, MD, Associate Professor, Medicine, Harvard Medical School, provides an overview of the current research in cellular biology, with a focus on primordial germ cells. As a noted researcher, Toshihiro Shioda, MD, Ph.D., has devoted a great deal of his life to the study of cellular activity and cellular processes. Shioda’s lab researches a vast array of important scientific areas including the role of estrogens and antiestrogens in human breast cancer. Shioda and his team have a particular interest in primordial germ cells (PGCs).  His research team studies how primordial germ cells share similarities to common, natural germ cells. And Shioda’s research may deliver a working model that could facilitate the analyzation of germline epimutations. The Ph.D. researcher discusses the details of chemotherapy and its impact on both sexes. Additionally, he cites various research regarding epigenetics. By using the leading tools available to them, Shioda and his team hope to deliver effective germ cell models that will be viable for cancer research as well as other areas of study.

Cellular Clues – Dr. Toshihiro Shioda, PhD, Associate Professor, Harvard Medical School – Exciting New Developments in Cellular Modeling That Could Enhance Disease Research

Toshihiro Shioda, MD, Ph.D., serves as Associate Professor, Medicine, Harvard Medical School and is a Member, MGH Cancer Center at Massachusetts General Hospital. Shioda discusses his lab’s work in regard to cellular biology.  Shioda’s lab studies a wide variety of issues such as the various roles and actions of certain estrogens and antiestrogens pertaining to breast cancer in humans, pharmacogenomics and toxicogenomics of estrogens as well as xenobiotic environmental estrogenic substances, and the impact of environmental materials and bioactive food elements on fetuses during early development, just to name a few. Shioda discusses primordial germ cells in detail, commonly referred to in the scientific community as simply, PGCs. As he states, PGCs are the basis for study for much of their lab research. By generating PGC-type models, the lab team members are able to study many areas related to cellular science. Shioda has published on multiple topics related to the field. The Harvard researcher is particularly interested in the various ways that primordial germ cells produced, and tested, within his lab are similar to typical, natural germ cells. Shioda talks about the possibilities for his team’s research, and how, notably, these types of cultured cells could provide a useful model in which to intensively study germline epimutations produced by an assortment of exposures. Continuing, Shioda talks about chemotherapy and the effects on men and women. He details some of the papers they have published on their studies of epigenetics. Epigenetics is defined as the study of heritable phenotype changes, changes that don’t require or pertain to alterations within the DNA sequence.  Shioda explains some of the difficulties researchers encounter. Specifically, in regard to fully comprehending germline exposure risks, there is a greater need for effectual, reliable models for important mechanical studies. Shioda and his research team utilize the most advanced tools related to stem cell biology as well as deep sequencing technology to produce germ cell models, with the intent of performing more toxicological tests that hopefully will provide answers to impact human health in a positive way, for cancer research and more.

Toshihiro Shioda, MD, Ph.D., serves as Associate Professor, Medicine, Harvard Medical School and is a Member, MGH Cancer Center at Massachusetts General Hospital. Shioda discusses his lab’s work in regard to cellular biology.  Shioda’s lab studies a wide variety of issues such as the various roles and actions of certain estrogens and antiestrogens pertaining to breast cancer in humans, pharmacogenomics and toxicogenomics of estrogens as well as xenobiotic environmental estrogenic substances, and the impact of environmental materials and bioactive food elements on fetuses during early development, just to name a few. Shioda discusses primordial germ cells in detail, commonly referred to in the scientific community as simply, PGCs. As he states, PGCs are the basis for study for much of their lab research. By generating PGC-type models, the lab team members are able to study many areas related to cellular science. Shioda has published on multiple topics related to the field. The Harvard researcher is particularly interested in the various ways that primordial germ cells produced, and tested, within his lab are similar to typical, natural germ cells. Shioda talks about the possibilities for his team’s research, and how, notably, these types of cultured cells could provide a useful model in which to intensively study germline epimutations produced by an assortment of exposures. Continuing, Shioda talks about chemotherapy and the effects on men and women. He details some of the papers they have published on their studies of epigenetics. Epigenetics is defined as the study of heritable phenotype changes, changes that don’t require or pertain to alterations within the DNA sequence.  Shioda explains some of the difficulties researchers encounter. Specifically, in regard to fully comprehending germline exposure risks, there is a greater need for effectual, reliable models for important mechanical studies. Shioda and his research team utilize the most advanced tools related to stem cell biology as well as deep sequencing technology to produce germ cell models, with the intent of performing more toxicological tests that hopefully will provide answers to impact human health in a positive way, for cancer research and more.

Cellular Activity – Toshihiro Shioda, MD, PhD, Associate Professor, Medicine, Harvard Medical School – New Developments In Cellular Research That Could Impact Human Health